Actively Recruiting
TINO: T Cells in the Nose of Older Adults
Led by Leiden University Medical Center · Updated on 2025-09-09
170
Participants Needed
1
Research Sites
274 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Rationale: Individuals with advanced age are at a progressively increasing risk of acquiring lower respiratory tract infections. Besides calendar age, the degree of frailty also associates with increased susceptibility to pneumonia requiring hospitalization. How alterations in the mucosal immune system with advanced age predispose to infections remains unclear as access to relevant tissue samples is limited. With minimally-invasive nasal sampling methods, it was recently observed that in vital older adults, both CD4+ T cells and CD8+ T cells are selectively lost from the nasal mucosa. However, the exact phenotype, underlying mechanisms, key molecules and consequences of this have not yet been investigated. Objective: Elucidate the mechanisms underlying the loss of nasal T cells and characterize in depth the differences of T cells in young and older adults and associate this loss with susceptibility to infections. Study design: Prospective cohort study Study population: Participants will be recruited from 3 groups: * healthy young adults (18-30 years, n=50) * vital older adults (\>65 years, n=60) * frail elderly (\>65 years, n=60). This group includes individuals without a history of recurrent respiratory infections or with \>2 self-reported episodes of respiratory infection in the past year. Main study parameters/endpoints: Frequency of nasal CD8+ T cells in young adults and frail older adults. Secondary study parameters/endpoints: * Phenotype (subsets, activation status), functionality, transcriptomic state, clonality and frequency of nasal and blood T cell populations * Stability of T cells and other immune parameters, as described for main study parameter, during a second sample after 3 months. * Analysis of other immune populations as for main study parameter * Concentration of nasal and systemic factors (e.g. cytokines and metabolites) and their association with T cells and other immune populations * Respiratory tract microbiota profiles and presence of asymptomatic viral infections and their association with T cells and other immune parameters * Chronological and biological age, sex, and other immunologically relevant parameters with T cell populations and other immune parameters * Alteration of T cell phenotype, during and following respiratory tract infections. Levels of antigen-specific T cells and other immune parameters in nose and blood post infection.
CONDITIONS
Official Title
TINO: T Cells in the Nose of Older Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults able and willing to provide informed consent
- Young adults aged 18-30 years
- Healthy elderly older than 65 years with Clinical Frailty score 1-3
- Frail elderly older than 65 years with Clinical Frailty score above 3
- Healthy elderly with 0-1 self-reported respiratory tract infections in the past year
- Frail elderly with any number of self-reported respiratory tract infections in the past year
You will not qualify if you...
- Unable to provide informed consent
- Current smoker or more than 40 pack year smoking history
- History of severe nose bleedings
- Diagnosed with asthma, COPD, or chronic rhinosinusitis
- Use of inhalation corticosteroids or antibiotics in the past 6 weeks
- Current use of anti-coagulants (except platelet inhibitors like acetylsalicylzuur)
- Respiratory tract infection or common cold in the past 2 weeks
- Immunocompromised individuals with primary or secondary immune deficiency
- Life expectancy less than 28 days as judged by the study physician
- Vaccination within 2 months prior to study start (may re-participate 2 months post vaccination)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Leiden University Medical Center
Leiden, South Holland, Netherlands, 2333ZA
Actively Recruiting
Research Team
S
Simon P Jochems, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here